These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10070983)

  • 61. Nephrotic syndrome and interstitial nephritis associated with celecoxib.
    Alper AB; Meleg-Smith S; Krane NK
    Am J Kidney Dis; 2002 Nov; 40(5):1086-90. PubMed ID: 12407655
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hypertension associated with therapies to treat arthritis and pain.
    White WB
    Hypertension; 2004 Aug; 44(2):123-4. PubMed ID: 15226278
    [No Abstract]   [Full Text] [Related]  

  • 63. Non-steroidal anti-inflammatory drugs in orofacial pain management--an update.
    van der Bijl P; van der Bijl P
    SADJ; 2002 Aug; 57(8):328-31. PubMed ID: 12428528
    [No Abstract]   [Full Text] [Related]  

  • 64. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.
    Steinbach G; Lynch PM; Phillips RK; Wallace MH; Hawk E; Gordon GB; Wakabayashi N; Saunders B; Shen Y; Fujimura T; Su LK; Levin B; Godio L; Patterson S; Rodriguez-Bigas MA; Jester SL; King KL; Schumacher M; Abbruzzese J; DuBois RN; Hittelman WN; Zimmerman S; Sherman JW; Kelloff G
    N Engl J Med; 2000 Jun; 342(26):1946-52. PubMed ID: 10874062
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Vioxx withdrawal alarms cancer prevention researchers.
    Vanchieri C
    J Natl Cancer Inst; 2004 Dec; 96(23):1734-5. PubMed ID: 15572751
    [No Abstract]   [Full Text] [Related]  

  • 66. The case of Abbokinase and the FDA: the events leading to the suspension of Abbokinase supplies in the United States.
    Hartnell GG; Gates J
    J Vasc Interv Radiol; 2000; 11(7):841-7. PubMed ID: 10928519
    [No Abstract]   [Full Text] [Related]  

  • 67. Urokinase and the US Food and Drug Administration.
    Ouriel K
    J Vasc Surg; 1999 Nov; 30(5):957-8. PubMed ID: 10550197
    [No Abstract]   [Full Text] [Related]  

  • 68. Fatal errors with cerebyx.
    Taylor K; Paparella S
    J Emerg Nurs; 2008 Oct; 34(5):460-1. PubMed ID: 18804724
    [No Abstract]   [Full Text] [Related]  

  • 69. Novel therapeutic options bring hope to patients with rheumatic conditions--and to the physicians who treat them.
    Pertusi RM
    J Am Osteopath Assoc; 1999 Jun; 99(6):300-1. PubMed ID: 10405514
    [No Abstract]   [Full Text] [Related]  

  • 70. The AGS' fondness for celecoxib.
    Finucane TE
    J Am Geriatr Soc; 2002 Sep; 50(9):1602; author reply 1602-3. PubMed ID: 12383165
    [No Abstract]   [Full Text] [Related]  

  • 71. Life-threatening hemothorax in a child following intrapleural administration of urokinase.
    Blom D; van Aalderen WM; Alders JM; Hoekstra MO
    Pediatr Pulmonol; 2000 Dec; 30(6):493. PubMed ID: 11109063
    [No Abstract]   [Full Text] [Related]  

  • 72. Specific cyclooxygenase 2 inhibitors: a new choice of nonsteroidal anti-inflammatory drug therapy.
    Osiri M; Moreland LW
    Arthritis Care Res; 1999 Oct; 12(5):351-62. PubMed ID: 11081005
    [No Abstract]   [Full Text] [Related]  

  • 73. Advisers recommend improved labeling for phenytoin, fosphenytoin.
    Traynor K
    Am J Health Syst Pharm; 2010 Dec; 67(24):2086, 2089. PubMed ID: 21115998
    [No Abstract]   [Full Text] [Related]  

  • 74. The coxib story: some lessons and more questions.
    Califf RM
    Am J Cardiol; 2002 Apr; 89(8):971-2. PubMed ID: 11950438
    [No Abstract]   [Full Text] [Related]  

  • 75. Future treatments for arthritis: new NSAIDs, NO NSAIDs, or no NSAIDs?
    Hawkey CJ
    Gastroenterology; 1995 Aug; 109(2):614-6. PubMed ID: 7615213
    [No Abstract]   [Full Text] [Related]  

  • 76. Induction of multidrug resistance proteins in lymphocytes from patients with arthritic disorders.
    Gradilone A; Spadaro A; Gianni W; Aglianò AM; Gazzaniga P
    Clin Exp Med; 2008 Dec; 8(4):229-30. PubMed ID: 18815867
    [No Abstract]   [Full Text] [Related]  

  • 77. Urokinase to return to market.
    Traynor K
    Am J Health Syst Pharm; 2002 Dec; 59(23):2278. PubMed ID: 12489364
    [No Abstract]   [Full Text] [Related]  

  • 78. FDA Arthritis Advisory Committee meeting.
    Paulus HE
    Arthritis Rheum; 1982 Sep; 25(9):1124-5. PubMed ID: 7126296
    [No Abstract]   [Full Text] [Related]  

  • 79. ZK 90 695: a new antiarthritic drug with tissue targeting properties.
    Hümpel M; Günzel P; Biere H; Junginger B
    Agents Actions; 1991 Jan; 32(1-2):22-3. PubMed ID: 2058464
    [No Abstract]   [Full Text] [Related]  

  • 80. Comment: NSAID substitution.
    Wilson FS
    DICP; 1989 May; 23(5):432. PubMed ID: 2728535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.